Chloroquine/Hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)

Registered study from Health research charity grants (360Giving). Evidence status: source reported.

Organisation

University of Oxford

Published

2020-09-30

Source reference

360G-Wellcome-221307_Z_20_Z

Jurisdiction

United Kingdom

Licence

Creative Commons Attribution 4.0 International (CC BY 4.0). Grant data published by Wellcome Trust in the 360Giving Data Standard, read through the 360Giving Datastore; named applicants and other individuals not imported.

Funder: Wellcome Trust · Recipient organisation: University of Oxford · Programme: Therapeutics Accelerator · Award: £6,920,135 · 2020-03-28 to 2022-12-27 · Found via: a paper's funding metadata

Source: https://grantnav.threesixtygiving.org/grant/360G-Wellcome-221307_Z_20_Z. Captured 2026-10-30.

Limitations: A Wellcome Trust grant named, by its number, in a held paper's funding metadata. The grant funded research; it does not show which data the research used.